MENU

FMS Stock Tickeron detected bullish Stock Pattern: Three Rising Valleys on April 01, 2025

A.I.dvisor
at Tickeron.com
Loading...
Three Rising Valleys
FMS - Fresenius Medical Care AG
Tickeron
Emerged: 04/01/25
Breakout: $24.9
Price: $24.9
Target price: $26.63
A.I.dvisor detected a bullish Three Rising Valleys pattern for FMS stock. This pattern was detected on April 01, 2025 . The odds of reaching the target price are 6. The Three Rising Valleys pattern forms when three minor Lows (1, 3, 5) are arranged along an upward sloping trend line. Consider buying a security or call option at the breakout price level. When trading, wait for the confirmation move, which is when the price rises above the breakout level.

Aroon Indicator for FMS shows an upward move is likely

FMS's Aroon Indicator triggered a bullish signal on April 01, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 267 similar instances where the Aroon Indicator showed a similar pattern. In of the 267 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on March 17, 2025. You may want to consider a long position or call options on FMS as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FMS just turned positive on March 07, 2025. Looking at past instances where FMS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

FMS moved above its 50-day moving average on March 14, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FMS crossed bullishly above the 50-day moving average on March 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FMS advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.762) is normal, around the industry mean (4.616). P/E Ratio (20.797) is within average values for comparable stocks, (71.885). FMS's Projected Growth (PEG Ratio) (0.452) is slightly lower than the industry average of (1.595). Dividend Yield (0.030) settles around the average of (0.026) among similar stocks. P/S Ratio (0.533) is also within normal values, averaging (9.164).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FMS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

View a ticker or compare two or three
FMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of renal and dialysis products

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
Else-Kroener-Strasse 1
Phone
+49 791033353
Employees
119845
Web
https://www.freseniusmedicalcare.com